GSK Gears Up For Three Cancer Launches In 2020
Oncology Pipeline Pivotal To Company’s Future
Executive Summary
After selling off its oncology franchise just five years ago, GSK is poised to re-enter the fray - and is preparing its commercial teams for battle.